NEURIM PHARMACEUTICALS RECEIVES EUROPEAN MARKETING AUTHORIZATION FOR PEDIATRIC PROLONGED-RELEASE MELATONIN (SLENYTO®) FOR THE TREATMENT OF INSOMNIA IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Bairong Inc. Announces 2024 Annual Financial Results
IMAGO Technologies Wins German Design Award 2025 & Launches FREE AI Online Whiteboard Trial
Zhihu Inc. Reports Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results
Cheetah Mobile Announces Fourth Quarter and Fiscal Year 2024 Unaudited Consolidated Financial Results
Antengene to Present Results From Four Cutting Edge Preclinical Studies at AACR 2025 with Focuses Including AnTenGagerTM TCEs and Synthetic Lethality
Fangzhou Inc. Partners with Tencent Health and Tencent Cloud to Accelerate Development of AI-Enabled Healthcare Services
GoodWe Powers Wildlife Rescue with Donated Solar System in Australia
